Hepatitis B Virus (HBV) Global Market Report 2024

Hepatitis B Virus (HBV) Global Market Report 2024 – By Type (Acute, Chronic), By Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery), By Age Group (Pediatrics, Adults, Seniors), By End User (Medical Providers, Patients, Healthcare Payers) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Hepatitis B Virus HBV Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Hepatitis B Virus (HBV) Market Definition And Segments

Hepatitis B virus (HBV) is a viral infection targeting the liver, transmitted via exposure to contaminated blood or bodily fluids or vertical transmission from mother to child during childbirth. Treatment involves antiviral medications to suppress viral replication, with vaccination being a crucial preventive measure.

The main types of hepatitis B virus (HBV) are acute and chronic. Acute hepatitis B refers to a short-term infection caused by the hepatitis B virus that occurs within the first six months of exposure to the virus and the medications aim to clear the virus from the body and prevent chronic infection. They are treated with immune modulator drugs, antiviral drugs, vaccines, and surgery for different age groups, such as pediatrics, adults, and seniors, by medical providers, patients, and healthcare payers.

The hepatitis b virus (hbv) market covered in this report is segmented –

1) By Type: Acute, Chronic

2) By Treatment: Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery

3) By Age Group: Pediatrics, Adults, Seniors

4) By End User: Medical Providers, Patients, Healthcare Payers

The hepatitis b virus (hbv) market size has grown rapidly in recent years. It will grow from $6.04 billion in 2023 to $6.71 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising prevalence of hepatitis b virus (hbv), growing demand for hbv diagnostics, expanding hbv vaccine coverage, rising awareness of hepatitis b virus (hbv).

The hepatitis b virus (hbv) market size is expected to see strong growth in the next few years. It will grow to $9.71 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rise of personalized medicine, growing support from patient advocacy groups, rising vaccination programs, increase in healthcare expenditure. Major trends in the forecast period include development of new drugs, advancements in diagnostic technologies, public-private partnerships, innovative biological therapies.

Rising Hepatitis B Infection Rates Fuel Growth Prospects For Hepatitis B Virus Market

The high prevalence of hepatitis B infection is expected to propel the growth of the hepatitis B virus market going forward. Hepatitis B is a liver infection brought on by the hepatitis B virus (HBV), which is prevented through vaccination. Rising hepatitis B infection rates can increase demand for diagnostic tests and treatment options. For instance, in December 2022, according to the European Centre for Disease Prevention and Control, a Sweden-based agency for strengthening Europe's defenses against infectious diseases, hepatitis B virus (HBV) infection was recorded in 16,187 cases in 30 Eastern European Member States in 2021. Further, the total cases 15,380 equal a crude rate of 4.7 cases per 100,000 people, compared to 14,332 in 2020. Therefore, the high prevalence of hepatitis B infection will drive the hepatitis B virus market.

Rising Incidences of Liver Damage and Cirrhosis Fuel Growth in Hepatitis B Virus Market

An increase in the incidences of patients with liver damage or cirrhosis is expected to propel the growth of the hepatitis B virus market going forward. Cirrhosis is a severe form of liver disease in which scar tissue permanently replaces good liver tissue. Hepatitis B virus Impact patient's kidney function while alleviating symptoms and adverse effects of the disorder. For instance, in September 2022, according to a Fact Sheet published by the Centers for Disease Control and Prevention, a US-based Government agency, the number of adults with diagnosed liver disease in the US was 4.5 million. Moreover, according to Medscape, a website providing access to medical information, states ALD-related fatalities increased by 17.6% between 2019 and 2021, whereas NAFLD-related deaths climbed by 14.5%. Therefore, the increase in the incidences of patients with liver damage or cirrhosis is driving the growth of the Hepatitis B virus market.

Major players in the hepatitis b virus (hbv) market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmon La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Eisai Co. Ltd., Aurobindo Pharma Limited, Apotex Corp., Lupin Pharmaceuticals Inc., Cadila Healthcare Ltd., Celltrion Inc., Dynavax Technologies Corporation, Accord Healthcare Inc., Par Pharmaceutical Inc., Arrowhead Pharmaceuticals Inc., Arbutus Biopharma Corporation, Globeimmune Inc., Antios Therapeutics Inc.

Increasing Healthcare Expenditure To Boost Market

The increasing healthcare expenditure is expected to restrain the growth of the hepatitis B virus (HBV) market’s growth during the forecast period. HBV screening is cost-effective, however, in countries with limited resources, the availability of point-of-care hepatitis B surface antigen tests and the prioritization of regular supply may be hampered by rising healthcare costs. This might result in patients getting delayed or ineffective care, and limited access to diagnostics. For instance, in May 2023, the Office for National Statistics, a UK-based government department, between 2020 and 2021, healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real ones. Furthermore, spending on preventive care was $45.72 billion in 2021, more than doubling from 2020. Therefore, the increasing healthcare expenditure is hindering the growth of the hepatitis B virus (HBV) market going forward .

Rising Emphasis On Highly Sensitive Hbsag Test Revolutionizes Hepatitis B Virus (HBV) Detection And Treatment

Major companies operating in the hepatitis B virus (HBV) market are focused on the development of advanced diagnostics and treatment options such as the use of highly sensitive chemiluminescent microparticle immunoassay (CMIA) to gain competitive advantages in the market. For instance, in May 2022, Abbott Laboratories, a US-based healthcare company, launched the HBsAg Next Qualitative Solution Test, which will aid in the early detection of Hepatitis B virus (HBV) in human serum and plasma samples and improve patient outcomes while preserving safe blood supplies. The early and improved detection of HBV in human serum and plasma (blood) samples, as well as population screening, are made possible by this highly sensitive chemiluminescent microparticle immunoassay (CMIA).

Brii Biosciences Acquires Licensing Rights For Hepatitis B Immunotherapy And Vaccine From Vbi Vaccines Inc

In July 2023, Brii Biosciences Ltd., a China-based biotechnology company, acquired licensing rights for an experimental hepatitis B immunotherapy and an approved hepatitis B vaccine from VBI Vaccines Inc. for an undisclosed amount. With this acquisition, Brii Biosciences Ltd. will have access to information on the prevention and treatment of the disease. VBI Vaccines Inc. is a US-based biotechnology company engaged in developing a vaccine to prevent infection caused by the hepatitis B virus.

North America was the largest region in the hepatitis B Virus (HBV) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hepatitis B virus (HBV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hepatitis B virus (HBV) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hepatitis B virus (HBV) market consists of revenues earned by entities by providing diagnostic testing for infection and monitoring of liver function. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis B virus (HBV) market also includes sales of tenofovir disoproxil, entecavir, telbivudine and lamivudine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The hepatitis B virus (HBV) market research report is one of a series of new reports from The Business Research Company that provides hepatitis B virus (HBV) market statistics, including hepatitis B virus (HBV) industry global market size, regional shares, competitors with a hepatitis B virus (HBV) market share, detailed hepatitis B virus (HBV) market segments, market trends and opportunities and any further data you may need to thrive in the hepatitis B virus (HBV) industry. This hepatitis B virus (HBV) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hepatitis B Virus (HBV) Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $6.71 billion
Revenue Forecast In 2033 $9.71 billion
Growth Rate CAGR of 9.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Acute, Chronic
2) By Treatment: Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery
3) By Age Group: Pediatrics, Adults, Seniors
4) By End User: Medical Providers, Patients, Healthcare Payers
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmon La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Bristol-Myers Squibb Company; AstraZeneca PLC; Sanofi SA; GlaxoSmithKline PLC; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Gilead Sciences Inc.; Boehringer Ingelheim International GmbH; Mylan N.V.; Teva Pharmaceutical Industries Ltd.; Vertex Pharmaceuticals Incorporated; Eisai Co. Ltd.; Aurobindo Pharma Limited; Apotex Corp.; Lupin Pharmaceuticals Inc.; Cadila Healthcare Ltd.; Celltrion Inc.; Dynavax Technologies Corporation; Accord Healthcare Inc.; Par Pharmaceutical Inc.; Arrowhead Pharmaceuticals Inc.; Arbutus Biopharma Corporation; Globeimmune Inc.; Antios Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Hepatitis B Virus (HBV) Market Characteristics

    3. Hepatitis B Virus (HBV) Market Trends And Strategies

    4. Hepatitis B Virus (HBV) Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Hepatitis B Virus (HBV) Market Size and Growth

    5.1. Global Hepatitis B Virus (HBV) Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Hepatitis B Virus (HBV) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Hepatitis B Virus (HBV) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Hepatitis B Virus (HBV) Market Segmentation

    6.1. Global Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Acute

    Chronic

    6.2. Global Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Immune Modulator Drugs

    Antiviral Drugs

    Vaccine

    Surgery

    6.3. Global Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Pediatrics

    Adults

    Seniors

    6.4. Global Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Medical Providers

    Patients

    Healthcare Payers

    7. Hepatitis B Virus (HBV) Market Regional And Country Analysis

    7.1. Global Hepatitis B Virus (HBV) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Hepatitis B Virus (HBV) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Hepatitis B Virus (HBV) Market  

    8.1. Asia-Pacific Hepatitis B Virus (HBV) Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Hepatitis B Virus (HBV) Market  

    9.1. China Hepatitis B Virus (HBV) Market Overview  

    9.2. China Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Hepatitis B Virus (HBV) Market  

    10.1. India Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Hepatitis B Virus (HBV) Market  

    11.1. Japan Hepatitis B Virus (HBV) Market Overview  

    11.2. Japan Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Hepatitis B Virus (HBV) Market  

    12.1. Australia Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Hepatitis B Virus (HBV) Market  

    13.1. Indonesia Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Hepatitis B Virus (HBV) Market  

    14.1. South Korea Hepatitis B Virus (HBV) Market Overview  

    14.2. South Korea Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Hepatitis B Virus (HBV) Market  

    15.1. Western Europe Hepatitis B Virus (HBV) Market Overview

    15.2. Western Europe Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Hepatitis B Virus (HBV) Market  

    16.1. UK Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Hepatitis B Virus (HBV) Market  

    17.1. Germany Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Hepatitis B Virus (HBV) Market  

    18.5. France Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Hepatitis B Virus (HBV) Market  

    19.9. Italy Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Hepatitis B Virus (HBV) Market  

    20.13. Spain Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Hepatitis B Virus (HBV) Market  

    21.1. Eastern Europe Hepatitis B Virus (HBV) Market Overview

    21.2. Eastern Europe Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Hepatitis B Virus (HBV) Market  

    22.1. Russia Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Hepatitis B Virus (HBV) Market  

    23.1. North America Hepatitis B Virus (HBV) Market Overview

    23.2. North America Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Hepatitis B Virus (HBV) Market  

    24.1. USA Hepatitis B Virus (HBV) Market Overview

    24.2. USA Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Hepatitis B Virus (HBV) Market  

    25.1. Canada Hepatitis B Virus (HBV) Market Overview

    25.2. Canada Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Hepatitis B Virus (HBV) Market  

    26.1. South America Hepatitis B Virus (HBV) Market Overview

    26.2. South America Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Hepatitis B Virus (HBV) Market  

    27.1. Brazil Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Hepatitis B Virus (HBV) Market  

    28.1. Middle East Hepatitis B Virus (HBV) Market Overview

    28.2. Middle East Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Hepatitis B Virus (HBV) Market  

    29.1. Africa Hepatitis B Virus (HBV) Market Overview

    29.2. Africa Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Hepatitis B Virus (HBV) Market Competitive Landscape And Company Profiles

    30.1. Hepatitis B Virus (HBV) Market Competitive Landscape

    30.2. Hepatitis B Virus (HBV) Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson Services Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmon La Roche Ltd.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck & Co. Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AbbVie Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Hepatitis B Virus (HBV) Market Other Major And Innovative Companies

    31.1. Bayer AG

    31.2. Bristol-Myers Squibb Company

    31.3. AstraZeneca PLC

    31.4. Sanofi SA

    31.5. GlaxoSmithKline PLC

    31.6. Takeda Pharmaceutical Company Limited

    31.7. Eli Lilly and Company

    31.8. Gilead Sciences Inc.

    31.9. Boehringer Ingelheim International GmbH  

    31.10. Mylan N.V.

    31.11. Teva Pharmaceutical Industries Ltd.

    31.12. Vertex Pharmaceuticals Incorporated

    31.13. Eisai Co. Ltd.

    31.14. Aurobindo Pharma Limited

    31.15. Apotex Corp.

    32. Global Hepatitis B Virus (HBV) Market Competitive Benchmarking

    33. Global Hepatitis B Virus (HBV) Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Hepatitis B Virus (HBV) Market

    35. Hepatitis B Virus (HBV) Market Future Outlook and Potential Analysis

    35.1 Hepatitis B Virus (HBV) Market In 2028 - Countries Offering Most New Opportunities

    35.2 Hepatitis B Virus (HBV) Market In 2028 - Segments Offering Most New Opportunities

    35.3 Hepatitis B Virus (HBV) Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Hepatitis B Virus (HBV) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Hepatitis B Virus (HBV) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Johnson & Johnson Services Inc. Financial Performance
  • Table 77: F. Hoffmon La Roche Ltd. Financial Performance
  • Table 78: Merck & Co. Inc. Financial Performance
  • Table 79: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Hepatitis B Virus (HBV) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Hepatitis B Virus (HBV) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Johnson & Johnson Services Inc. Financial Performance
  • Figure 77: F. Hoffmon La Roche Ltd. Financial Performance
  • Figure 78: Merck & Co. Inc. Financial Performance
  • Figure 79: AbbVie Inc. Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Liver Diseases Therapeutics Global Market Report 2024 – By Disease Type( Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer ), By Treatment( Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids ), By End User( Hospitals, Ambulatory Surgery Centers, Other End Users ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Liver Cancer Diagnostics Global Market Report 2024 – By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types), By Screening (Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies), By End Use (Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Human Liver Model Global Market Report 2024 – By Product (Liver Organoids, Liver-On-A-Chip, 2D Models, Animal Models, 3D Bioprinting), By Application (Educational, Drug Discovery, Other Applications), By End Users (Research Institutes, Pharmaceutical Companies, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Fatty Liver Treatment Global Market Report 2024 – By Treatment Type (Anti-Rejection Drugs Or Immunosuppressants, Chemotherapy Drugs, Targeted Therapy, Vaccines, Anti-Viral Drugs), By Disease Type (Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases), By End User (Hospitals, Ambulatory Surgery Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Herpes Simplex Virus Treatment Global Market Report 2024 – By Type (Herpes Simplex Virus-1 Infection, Herpes Simplex Virus-2 Infection), By Drug Type (Acyclovir, Valacyclovir, Famciclovir, Other Drugs), By Route Of Administration (Oral, Injection, Topical), By Vaccine (Simplirix, Other Vaccines), By Distribution Channel (Hospital Pharmacies, Drug store, Retail Pharmacies, Online Providers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Human Papillomavirus (HPV) Vaccine Global Market Report 2024 – By Type (Tetravalent, Nonavalent, Bivalent), By Disease Indication (Cervical Cancer, Anal Cancer, Vulvar And Vaginal Cancer, Penile Cancer, Oropharyngeal Cancer, Other Indications), By Distribution Channel (Hospital And Retail Pharmacies, Government Suppliers, Other Channels), By Industry Vertical (Public And Private Alliance, Government Entities, Physicians, Other Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Oncolytic Virus Therapy Global Market Report 2024 – By Therapy Type (HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types), By Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), By Application (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer), By End-User (Hospitals, Specialty Clinics, Cancer Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Syncytial Virus (RSV) Therapeutics Global Market Report 2024 – By Drug (Palivizumab, Ribavirin, Other Drugs), By Treatment (Immune Prophylaxis, Supportive Care, Antiviral Medications), By Dosage Form (Oral, Injectable, Other Dosage Forms), By Patient Type (Pediatrics, Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the hepatitis b virus (HBV) market?

Hepatitis B virus (HBV) is a viral infection targeting the liver, transmitted via exposure to contaminated blood or bodily fluids or vertical transmission from mother to child during childbirth. Treatment involves antiviral medications to suppress viral replication, with vaccination being a crucial preventive measure. request a sample here

How will the hepatitis b virus (HBV) market drivers and restraints affect the hepatitis b virus (HBV) market dynamics? What forces will shape the hepatitis b virus (HBV) industry going forward?

The hepatitis b virus (HBV) market major growth driver - Rising Hepatitis B Infection Rates Fuel Growth Prospects For Hepatitis B Virus Market. request a sample here

What is the forecast market size or the forecast market value of the hepatitis b virus (HBV) market?

The hepatitis b virus (HBV) market size has grown rapidly in recent years. It will grow from $6.04 billion in 2023 to $6.71 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising prevalence of hepatitis b virus (HBV), growing demand for hbv diagnostics, expanding hbv vaccine coverage, rising awareness of hepatitis b virus (HBV). The hepatitis b virus (HBV) market size is expected to see strong growth in the next few years. It will grow to $9.71 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rise of personalized medicine, growing support from patient advocacy groups, rising vaccination programs, increase in healthcare expenditure. Major trends in the forecast period include development of new drugs, advancements in diagnostic technologies, public-private partnerships, innovative biological therapies. request a sample here

How is the hepatitis b virus (HBV) market segmented?

The hepatitis b virus (HBV) market is segmented
1) By Type: Acute, Chronic
2) By Treatment: Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery
3) By Age Group: Pediatrics, Adults, Seniors
4) By End User: Medical Providers, Patients, Healthcare PayersFor further insights on the hepatitis b virus (HBV) market request a sample here

Which region has the largest share of the hepatitis b virus (HBV) market? What are the other regions covered in the report?

North America was the largest region in the hepatitis B Virus (HBV) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hepatitis B virus (HBV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the hepatitis b virus (HBV) market?

Major players in the hepatitis b virus (HBV) market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmon La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Eisai Co. Ltd., Aurobindo Pharma Limited, Apotex Corp., Lupin Pharmaceuticals Inc., Cadila Healthcare Ltd., Celltrion Inc., Dynavax Technologies Corporation, Accord Healthcare Inc., Par Pharmaceutical Inc., Arrowhead Pharmaceuticals Inc., Arbutus Biopharma Corporation, Globeimmune Inc., Antios Therapeutics Inc. request a sample here.

What are the key trends in the hepatitis b virus (HBV) market?

Major trend in the hepatitis b virus (HBV) market - Rising Emphasis On Highly Sensitive Hbsag Test Revolutionizes Hepatitis B Virus (HBV) Detection And Treatment. request a sample here.

What are the major opportunities in the hepatitis b virus (HBV) market? What are the strategies for the hepatitis b virus (HBV) market?

For detailed insights on the major opportunities and strategies in the hepatitis b virus (HBV) market, request a sample here.

How does the hepatitis b virus (HBV) market relate to the overall economy and other similar markets?

For detailed insights on hepatitis b virus (HBV) market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the hepatitis b virus (HBV) industry?

For detailed insights on the mergers and acquisitions in the hepatitis b virus (HBV) industry, request a sample here.

What are the key dynamics influencing the hepatitis b virus (HBV) market growth? SWOT analysis of the hepatitis b virus (HBV) market.

For detailed insights on the key dynamics influencing the hepatitis b virus (HBV) market growth and SWOT analysis of the hepatitis b virus (HBV) industry, request a sample here.